138 related articles for article (PubMed ID: 1153625)
1. The role of noradrenaline, dopamine and 5-hydroxytryptamine in the hyperactivity response resulting from the administration of tranylcypramine to rats pretreated with lithium or rubidium.
Judd A; Parker J; Jenner FA
Psychopharmacologia; 1975 Apr; 42(1):73-7. PubMed ID: 1153625
[TBL] [Abstract][Full Text] [Related]
2. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
Grahame-Smith DG; Green AR
Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
[TBL] [Abstract][Full Text] [Related]
3. Proceedings: The effects of lithium, rubidium and caesium on the response of rats to tranylcypromine and alpha-methyl-p-tyrosine given separately or in combination.
Jenner FA; Judd A; Parker J
Br J Pharmacol; 1975 Jun; 54(2):233P-234P. PubMed ID: 1148523
[No Abstract] [Full Text] [Related]
4. Role of brain amines in the fetal hyperpyrexia caused by tranylcypromine in LiCl-pretreated rats.
Shimomura K; Hashimoto M; Mori J; Honda F
Jpn J Pharmacol; 1979 Apr; 29(2):161-70. PubMed ID: 161335
[TBL] [Abstract][Full Text] [Related]
5. The effects of rubidium, caesium and quinine on 5-HT-mediated behaviour in rat and mouse--1. Rubidium.
Wang H; Grahame-Smith DG
Neuropharmacology; 1992 May; 31(5):413-9. PubMed ID: 1382243
[TBL] [Abstract][Full Text] [Related]
6. [Effects of lithium chloride on norepinephrine and dopamine metabolism in the rat brain].
Nozu T; Furukawa T
Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):619-25. PubMed ID: 1033111
[TBL] [Abstract][Full Text] [Related]
7. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
Green AR; Youdim MB
Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
[TBL] [Abstract][Full Text] [Related]
8. Interactions of non-selective monoamine oxidase inhibitors, tranylcypromine and nialamide, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake.
Marley E; Wozniak KM
J Psychiatr Res; 1984; 18(2):191-203. PubMed ID: 6235366
[TBL] [Abstract][Full Text] [Related]
9. Lithium: modification of behavioral activity and brain biogenic amines in developing hyperthyroid rats.
Rastoge RB; Singhal RL
J Pharmacol Exp Ther; 1977 Apr; 201(1):92-102. PubMed ID: 850149
[TBL] [Abstract][Full Text] [Related]
10. Effects of tranylcypromine stereoisomers, clorgyline and deprenyl on open field activity during long term lithium administration in rats.
Smith DF
Psychopharmacology (Berl); 1976 Oct; 50(1):81-4. PubMed ID: 827767
[TBL] [Abstract][Full Text] [Related]
11. Effects of alpha methyltyrosine and parachlorophenylalanine on open field behavior in rats given tranylcypromine stereoisomers and lithium carbonate.
Smith DF; Shimizu M
Pharmacol Biochem Behav; 1976 Nov; 5(5):515-8. PubMed ID: 138857
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours.
Finberg JP; Youdim MB
Neuropharmacology; 2002 Dec; 43(7):1110-8. PubMed ID: 12504917
[TBL] [Abstract][Full Text] [Related]
13. Effects of mazindol, a non-phenylethylamine anorexigenic agent, on biogenic amine levels and turnover rate.
Carruba MO; Groppetti A; Mantegazza P; Vicentini L; Zambotti F
Br J Pharmacol; 1976 Apr; 56(4):431-6. PubMed ID: 1260223
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of the uptake of monoamines into synaptosomes from rat brain. Consequences of lithium treatment and withdrawal.
Ahluwalia P; Singhal RL
Neuropharmacology; 1985 Aug; 24(8):713-20. PubMed ID: 3837858
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical changes in rat brain amines after short- and long-term inhibition of monoamine oxidase by a low dose of tranylcypromine.
Hampson DR; Baker GB; Coutts RT
Biol Psychiatry; 1988 Feb; 23(3):227-36. PubMed ID: 3337860
[TBL] [Abstract][Full Text] [Related]
16. The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.
Green AR; Grahame-Smith DG
Neuropharmacology; 1974 Nov; 13(10-11):949-59. PubMed ID: 4437730
[No Abstract] [Full Text] [Related]
17. Effects of lithium and rubidium on antinociception and behaviour in mice. I. Studies on narcotic analgesics and antagonists.
Saarnivaara L; Männistö PT
Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):282-92. PubMed ID: 10866
[TBL] [Abstract][Full Text] [Related]
18. Effects of repeated lithium administration on the subcellular distribution of 5-hydroxytryptamine in rat brain.
Atterwill CK; Tordoff AF
Br J Pharmacol; 1982 Jul; 76(3):413-21. PubMed ID: 7104517
[TBL] [Abstract][Full Text] [Related]
19. Proceedings: The role of brain dopamine in the hyperactivity syndrome produced in rats after administration of L-tryptophan and a monoamine oxidase inhibitor.
Grahame-Smith DG; Green AR
Br J Pharmacol; 1974 Mar; 50(3):442P-443P. PubMed ID: 4853875
[No Abstract] [Full Text] [Related]
20. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration.
Sherry-McKenna RL; Baker GB; Mousseau DD; Coutts RT; Dewhurst WG
Biol Psychiatry; 1992 May; 31(9):881-8. PubMed ID: 1353376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
